Form 4 Tracker
David A Ramsay

Interim CFO · 1 filing · Latest: Apr 1, 2026

HALOZYME THERAPEUTICS, INC.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
SVRA
RAMSAY DAVID ADec 18, 2025
Proposed Sale
$6.1120,000$122.2K